Time to consider death in clinical trials for PAH

Paul M. Hassoun

doi:10.1016/S2213-2600(16)30308-3

Time to consider death in clinical trials for PAH

Paul M. Hassoun

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	849-850
Number of pages	2
Journal	The Lancet Respiratory Medicine
Volume	4
Issue number	11
DOIs	https://doi.org/10.1016/S2213-2600(16)30308-3
State	Published - Nov 1 2016

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1016/S2213-2600(16)30308-3

Cite this

@article{a8ab16da892c4e80b9fcd3927eedf98f,

title = "Time to consider death in clinical trials for PAH",

author = "Hassoun, {Paul M.}",

year = "2016",

month = nov,

day = "1",

doi = "10.1016/S2213-2600(16)30308-3",

language = "English (US)",

volume = "4",

pages = "849--850",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier Limited",

number = "11",

}

TY - JOUR

T1 - Time to consider death in clinical trials for PAH

AU - Hassoun, Paul M.

PY - 2016/11/1

Y1 - 2016/11/1

UR - http://www.scopus.com/inward/record.url?scp=84994805916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994805916&partnerID=8YFLogxK

U2 - 10.1016/S2213-2600(16)30308-3

DO - 10.1016/S2213-2600(16)30308-3

M3 - Comment/debate

C2 - 27745819

AN - SCOPUS:84994805916

SN - 2213-2600

VL - 4

SP - 849

EP - 850

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

IS - 11

ER -

Time to consider death in clinical trials for PAH

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this